Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant Application
The Institute for Medical Research Israel-Canada – $40,000 USD / 143,580 INS
$40,000.00 USD
December 2024
CXCR1/2 Signaling Pathway: A Role in the Invasive Mechanism of DIPG
Children's Healthcare of Atlanta – $100,000
$100,000.00 USD
November 2024
Radiation Resistance in Medulloblastoma
University of Texas Health Science Center at San Antonio – $100,000
$100,000.00 USD
November 2024
Targeting Metabolic Vulnerabilities for Treating Medulloblastoma
University of Texas Health Science Center at San Antonio – $50,000
$50,000.00 USD
November 2024
Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma
Children’s National Medical Center – $300,000
$300,000.00 USD
November 2024
Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.
Children's Hospital Los Angeles – $100,000
$100,000.00 USD
October 2024
Targeting FOXR2 in Diffuse Midline Gliomas
University Hospital of Navarra - $100,000 USD, €92,637 EUR
$100,000.00 USD
October 2024
Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.
The Institute of Cancer Research – $111,445 USD / £85,976 GBP
$111,445.00 USD
October 2024
Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.
Cincinnati Children’s Hospital Medical Center - $170,953
$170,953.00 USD
October 2024
Combining FLASH and immunotherapy to target medulloblastoma relapse
Emory University / Cincinnati Children's Hospital – $92,831
$92,831.00 USD
March 2024
SUMOylation as a novel therapeutic target in DIPG
University of Chicago Medical Center / Washington University St. Louis – $100,000
$100,000.00 USD
December 2023
Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.
Icahn School of Medicine at Mount Sinai – $100,000
$100,000.00 USD
December 2023
Targeting macrophages to improve the survival of DIPG
Children’s Hospital Colorado – $98,551
$98,551.00 USD
December 2023
Dual targeting processive transcription for Myc-driven circuitry in medulloblastoma.
Princess Máxima Center for Pediatric Oncology – $98,306
$98,306.00 USD
December 2023
Assessing the potential of the HDAC inhibitor givinostat ± radiotherapy for the treatment of diffuse midline glioma.
Nemours Children’s Hospital - $49,885
$49,885.00 USD
December 2023
Treatment of Diffuse Intrinsic Pontine Glioma with the Oncolytic Zika Virus.